Share Name Share Symbol Market Type Share ISIN Share Description
Fitbug LSE:FITB London Ordinary Share GB00B57JBH88 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.525p +318.18% 0.69p 0.68p 0.70p 0.695p 0.185p 0.19p 783,515,996.00 13:57:48
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Leisure Goods 1.3 -6.5 -2.5 - 8.50

Fitbug (FITB) Latest News (4)

More Fitbug News
Fitbug Takeover Rumours

Fitbug (FITB) Share Charts

1 Year Fitbug Chart

1 Year Fitbug Chart

1 Month Fitbug Chart

1 Month Fitbug Chart

Intraday Fitbug Chart

Intraday Fitbug Chart

Fitbug (FITB) Discussions and Chat

Fitbug (FITB) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
13:56:220.6320,449128.83O
13:56:060.63247,8901,561.71O
13:56:040.63102,833647.85O
13:55:560.6120,000121.98O
13:55:520.64125,000793.75O
View all Fitbug trades in real-time

Fitbug (FITB) Top Chat Posts

DateSubject
18/1/2017
08:20
Fitbug Daily Update: Fitbug is listed in the Leisure Goods sector of the London Stock Exchange with ticker FITB. The last closing price for Fitbug was 0.17p.
Fitbug has a 4 week average price of 0.17p and a 12 week average price of 0.21p.
The 1 year high share price is 1.20p while the 1 year low share price is currently 0.16p.
There are currently 1,231,366,968 shares in issue and the average daily traded volume is 5,352,807 shares. The market capitalisation of Fitbug is £6,156,834.84.
18/1/2017
12:51
mr hat: Fitbug shares more than double as it announces new customer win 10:10 18 Jan 2017 The fitness tracking group has inked a deal with a global financial services firm in Asia Business are starting to take the health of their employees more seriously Fitbug Holdings PLC’s (LON:FITB) move into the corporate wellness sector is continuing to pay dividends after the group announced a new customer win in Asia. The unnamed global financial services group – which has around 14,000 employees – will use Fitbug’s digital wellness services to help maximise workforce performance and productivity. London-based Fitbug has secured a one-year corporate wellness programme deal which includes ongoing service revenue as well as an order for 14,000 devices. The devices were shipped out last month and the programme is slated to start early this year. Fitbug is benefitting as businesses start to take the health of their employee’s more seriously in order to reduce absenteeism and risk of chronic illness, as well as to improve employee engagement. Shares in Fitbug went through the roof on Wednesday morning, up more than 110% at 9am to trade at 0.35p. Shares were up by almost 150%, or 0.24p, on Wednesday morning and were changing hands at 0.41p a pop. Not the easiest of rides Last year was a busy one for Fitbug as it looked to get its finances and operations back on track following a disappointing run during which losses continued to widen. The company changed tack and started to cut back on its “unsustainable” retail business and focus on opportunities within the corporate wellness sector last summer. Just before that, it had settled a long-running dispute with fellow health tech group Fitbit (NYSE:FIT) which had been costing hundreds of thousands of pounds in legal fees. Fitbug, which was established two years before Fitbit in 2005, argued that the similarity of the names created confusion and was damaging to its business and brand identity. The two settled out of court in a confidential agreement in February 2016. With a new strategy and freed from the legal issues that had clouded the business, Fitbug set about securing the finances to bring about a new dawn for the company. Its original founders, David Turner and Allan Fisher, agreed to convert an £8.4mln debt owed by the company to them into shares, while it also raised a further £2.6mln through another share issue. In its interims back in September, the company posted a loss of more than £1.6mln, although this was around half of the losses accrued in the same period a year earlier. -- Updates for background info and share price -- [...]
16/1/2017
11:29
mudbath: Kendonagasaki-You pays your money. At least the appointment of SPARK as Nomad to Fitbug has coincided with an adjustment of the share price;now more reflecting the prices available. As Dusseldorf points out though,one can buy this morning at 0.1595,so a little further markdown would be more reflective of the actuality . Where next ?
18/12/2016
10:13
mudbath: KNIGELK said the other day that,"We all make mistakes and/or errors of judgement - especially with investment." Individually,that is very true and most,including myself,are now showing a loss on FITB. Yet the constituents of the "concert party",supporting Fitbug ,go way beyond any one individual getting it wrong.Indeed recent history shows of a wide group of very talented individuals having and continuing to provide significant funds thus enabling Fitbug to continue trading.These funds will undoubtedly be lost unless FITB in its present form achieves traction and profitability,or more likely,imo,something is put into the public domain that causes the share price to move upwards very significantly. Looking at the Concert Party we see heavyweights such as NW1, Kifin(being a Kirsh group subsidiary, Prime Interaction(Prime Interaction is an investment holding company whose directors are Barry Stiefel (who was also the manager of the Kirsh family office) and Robin Fisher. Mr Fisher has, in addition, a distant family connection with Mr Kirsh)together with the Holmes Place owners Allan Fisher, David Turner and members of their immediate families. There are countless ways by which ANY member of the Concert Party could stimulate investor interest in Fitbug and I would be both surprised and disappointed if we do not receive news on this front at some stage.
27/11/2016
09:26
knigel: Do you work for Fitbug? So much promotion - so little movement in share price or RNSs from the company - BBs do not move share prices - news from the company will..
23/12/2015
16:32
liquid millionaire: FITB obviously have some serious supporters who truly believe in what they are doing. Todays RNS is better much better than endless dilutive share placings. I for one like it and can see why the FITB share price has responded the way that it has i.e. positive +
10/12/2014
13:40
liquid millionaire: FITB Repeat FITB Just out ref: FITB Subject: Fitbug Holdings PLC: £3.5m placing to fund sales drive Hybridan Research The provider of online personal health and wellbeing services yesterday announced a placing of £3.5m at a price of 9p. Fitbug has announced a string of high profile partnerships and retail agreements of late with the likes of Target and Samsung UK which sent the share price up to as high as 26.375p on an intraday basis. The funds will be predominantly applied to the marketing of the Fitbug Orb and the recently launched online coaching platform, Kiqplan, which is compatible with the majority of wearable devices. This combination, in our opinion, gives Fitbug a unique position to capitalise upon the fast growing demand for wearable technology, and incorporation of fitness tracking sensors into smartphones. We understand that the marketing strategy will be primarily focused on the US and UK. Fitbug will be attending the Consumer Electronics Show in January. Kiqplan has relevance to anybody wishing to achieve lifestyle improvement goals, and as such sponsorship of high profile public sporting events (fun runs etc) will provide a viable platform to reach new audiences. We also understand that Fitbug is pursuing a number of further retail partnerships and is seeking to appoint a global head of marketing. The admission of the placing shares on 30 December will be accompanied by the issue of 33.3m shares in respect of the conversion of 50% of a £1m loan note from Kifin Limited, a Kirsh Group subsidiary. Under the terms of the note issued in 2012 the conversion price is 1.5p. The company has for some time relied on the support of the Kirsh Group and NW1 Investments (a related party). The continuing support was demonstrated as recently as the 26 November announcement of the extension of all other loans to July 2016 (£6.9m). Within that figure is included loan proceeds of £2.35m issued in H2 2014. These funds combined with the placing proceeds, give Fitbug the resources to maximise its first mover advantage, and the opportunity to reach profitability with no further support from external backers. There are currently 13 million options of which 3 million are being surrendered and an additional 13.1 million are being granted including 8.5million to directors at the placing price under the enterprise management incentive scheme. David Turner, who currently holds 3m options intends to surrender these immediately after Admission following his move to a non-executive role earlier in 2014. CEO Malcolm Fried, having completed his task of refreshing Fitbug’s strategic direction, will be stepping down at the year end and Chairman, Fergus Kee, will revert to his executive role. Paul Landau, the founder of the Fitbug business, remains CEO of Fitbug Limited, the main operating company The combination of rapidly expanding retail base, and the high margin scalable cross-platform Kiqplans, give us confidence that H2 2014 and beyond will demonstrate rapid revenue growth. Should Target alone gross $100 per store per week in sales of Fitbug products that would add circa £3m in annual revenues. At this stage of Fitbug’s aggressive growth drive, revenue visibility is limited and we look forward to further details of due course. As we detailed in our note of 24 October, the wearable space has been the subject of much corporate activity with several transactions going through in excess of $100m. We believe that Fitbug’s capability of reaching multiple devices is unique in that it enables the company to target a higher proportion of the customers expected to buy over 43m of wearable bands worldwide next year. The recent launch of the Samsung Gear S and ever evolving pipeline of new devices, such as the Apple iWatch due for release in spring 2015 will keep the sector in focus for some time to come. The litigation against the market leader in basic bands, Fitbit, for trademark infringement is due to reach the courts in February 2015. We understand from the company that there is likely to be little downside and potentially significant upside for Fitbug from this case, and that under the US legal system costs cannot be awarded against a litigant who fails to prove their case. Fitbit on the other hand would appear to have much at risk including the potential loss of the Fitbit mark.
10/12/2014
11:55
liquid millionaire: Just out ref: FITB Subject: Fitbug Holdings PLC: £3.5m placing to fund sales drive Hybridan Research The provider of online personal health and wellbeing services yesterday announced a placing of £3.5m at a price of 9p. Fitbug has announced a string of high profile partnerships and retail agreements of late with the likes of Target and Samsung UK which sent the share price up to as high as 26.375p on an intraday basis. The funds will be predominantly applied to the marketing of the Fitbug Orb and the recently launched online coaching platform, Kiqplan, which is compatible with the majority of wearable devices. This combination, in our opinion, gives Fitbug a unique position to capitalise upon the fast growing demand for wearable technology, and incorporation of fitness tracking sensors into smartphones. We understand that the marketing strategy will be primarily focused on the US and UK. Fitbug will be attending the Consumer Electronics Show in January. Kiqplan has relevance to anybody wishing to achieve lifestyle improvement goals, and as such sponsorship of high profile public sporting events (fun runs etc) will provide a viable platform to reach new audiences. We also understand that Fitbug is pursuing a number of further retail partnerships and is seeking to appoint a global head of marketing. The admission of the placing shares on 30 December will be accompanied by the issue of 33.3m shares in respect of the conversion of 50% of a £1m loan note from Kifin Limited, a Kirsh Group subsidiary. Under the terms of the note issued in 2012 the conversion price is 1.5p. The company has for some time relied on the support of the Kirsh Group and NW1 Investments (a related party). The continuing support was demonstrated as recently as the 26 November announcement of the extension of all other loans to July 2016 (£6.9m). Within that figure is included loan proceeds of £2.35m issued in H2 2014. These funds combined with the placing proceeds, give Fitbug the resources to maximise its first mover advantage, and the opportunity to reach profitability with no further support from external backers. There are currently 13 million options of which 3 million are being surrendered and an additional 13.1 million are being granted including 8.5million to directors at the placing price under the enterprise management incentive scheme. David Turner, who currently holds 3m options intends to surrender these immediately after Admission following his move to a non-executive role earlier in 2014. CEO Malcolm Fried, having completed his task of refreshing Fitbug’s strategic direction, will be stepping down at the year end and Chairman, Fergus Kee, will revert to his executive role. Paul Landau, the founder of the Fitbug business, remains CEO of Fitbug Limited, the main operating company The combination of rapidly expanding retail base, and the high margin scalable cross-platform Kiqplans, give us confidence that H2 2014 and beyond will demonstrate rapid revenue growth. Should Target alone gross $100 per store per week in sales of Fitbug products that would add circa £3m in annual revenues. At this stage of Fitbug’s aggressive growth drive, revenue visibility is limited and we look forward to further details of due course. As we detailed in our note of 24 October, the wearable space has been the subject of much corporate activity with several transactions going through in excess of $100m. We believe that Fitbug’s capability of reaching multiple devices is unique in that it enables the company to target a higher proportion of the customers expected to buy over 43m of wearable bands worldwide next year. The recent launch of the Samsung Gear S and ever evolving pipeline of new devices, such as the Apple iWatch due for release in spring 2015 will keep the sector in focus for some time to come. The litigation against the market leader in basic bands, Fitbit, for trademark infringement is due to reach the courts in February 2015. We understand from the company that there is likely to be little downside and potentially significant upside for Fitbug from this case, and that under the US legal system costs cannot be awarded against a litigant who fails to prove their case. Fitbit on the other hand would appear to have much at risk including the potential loss of the Fitbit mark.
27/11/2014
09:15
waspfactory: Act your age not the FITB share price
25/11/2014
17:30
leebong: It’s been a fantastic few weeks for investors in Fitbug (LSE: FITB), with shares in the seller of fitness devices rising by a whopping 320% in the last week, and an incredible 5272% in the last month. The key reason for their very recent gains has been a deal struck with Samsung, with the electronics giant agreeing to include the company’s KiQplan digital coaching product on its Digital Health platform. The agreement could help to improve consumer awareness of Fitbug and, with the company offering additional features that are exclusively available to Samsung customers (such as a 12-week plan called ‘Fit+Healthy’), the move could help to build brand loyalty among Samsung customers. In addition, shares in Fitbug have also benefited in recent weeks from the stocking of the company’s products in Sainsbury’s, as well as in Target stores in the US. With such major retailers getting on board, the market clearly believes that Fitbug could have a bright future, and more major retailers could follow their peers and begin to stock the company’s products. Future Potential Clearly, wearable technology devices such as those sold by Fitbug have huge growth potential. Furthermore, when they are combined with a focus on health and wellbeing, it could prove to be a potent mix and, in this respect, Fitbug seems to have superb potential. In addition, a glance at Fitbug’s offering confirms that it could develop a niche product. That’s because it offers the same features as more expensive options, such as those sold by Nike, for a fraction of the cost. So, Fitbug could carve out its own segment in a fast-growing industry and make health-focused wearable technology devices much more accessible for consumers. This could be hugely beneficial to investors through a higher share price. Looking Ahead Of course, Fitbug remains a company that has no revenue and is therefore impossible to value. Furthermore, the chances of the company’s share price continuing its rise at the same pace are slim. After all, it has struck multiple deals with major corporations and, while others may follow, they are unlikely to cause such a dramatic rise in the company’s share price in the short run. That’s because further success appears to now be priced in, with the market seemingly anticipating sales figures to impress over the near term. Although wearable technology focused on health and wellbeing is undoubtedly an industry with vast potential, whether Fitbug can tap into that growth is yet to be tested. As a result, Fitbug remains a very high-risk play, with its share price set to remain volatile until data regarding its sales comes through. As such, prudent investors may wish to wait for evidence of its success – especially after a period of such strong share price growth – before buying a slice of the company. After all, patience has never lost anyone any money. Clearly, investing in Fitbug has been a highly profitable move for most investors in the stock
28/10/2014
11:55
mudbath: Retail contracts for the Orb have no bearing on the FITB share price rise imo. We are seeing the EARLY STAGES of recognition that Nathan Kirsh via Kilfin might inject his US $ 6 BILLION private company assets into what,on conversion of outstanding loans (some at 1.5pence)would be a shell controlled by Kirsh and existing directors.They are currently mopping up the free float. Just surprised that it took so long for people to spot the glaring potential for the share price to rise not to 10 pence but to many multiples of that figure. (posted last year. On the face of it Fitbug is the next AIM candidate for administration,boasting a negative shareholder equity of £1.88 million against a current market cap of £1.4million,a loss for the past 6 months of £1.05 million on declining revenues of just £461k. It has been able to continue trading purely on the back of loans provided by the Kirch Group and associated companies. These loans total a staggering(relatively speaking)£3.75 million. £2.75million of the loans are repayable in 6 months time with the remaining £1million in 18 months. Subject to certain criteria,the loans are convertible. Whilst a significant uplift in revenues is forecast,it seems impossible that FITB will be able repay all or part of these loans,meaning that the Kirsh Group and those other private companies working in tandem, could end up, following conversion of loans into shares,of some 80% of the enlarged equity. Nathan Kirsh, who has a net worth of at least $5.1 billion, according to the Bloomberg Billionaires Index is 81 years old and is making plans to hand over the reins of control. “We are private, we are profitable and we have fun,” the billionaire, who has never appeared on an international wealth ranking, said in an interview at his office in North London in October. “We just don’t scream about what we do.” In October, Kirsh acquired a white-stucco fronted Georgian building next to London’s Madame Tussauds waxworks tourist attraction near Regents Park. The building will become the new headquarters for the Kirsh Group in June, bringing his disparate portfolio of assets and businesses under one roof for the first time. The operation, he said, will one day be managed by Ron Sandler, the former CEO of the Lloyd’s of London insurance market who was also appointed by the U.K. government as chairman of Northern Rock Plc, which was nationalized in 2008. Kirsh states, “All of my businesses are profitable. I am in the best space I have ever been.” My reason for investing and believing that FITB could at least double is based solely on the involvement of the Kirsh family,the singular mismatching of their status and level of support in relation to Fitbug's size and ability to repay,paving the way for FITB to become a majority owned company and a possible vehicle for the injection of Kirsh Group assets. At worst Fitbug could end up fully funded at the commencement of on upward trend in its fortunes. Finally, the expansion of Fitbit,a similarly named US$300million capitalized US competitor has resulted in a quantum leap in traffic to the FITB web site. Fitbug are currently involved in legal action against Fitbit in the US claiming breach of copyright. Pure speculation of course. Nevertheless FITB should be an interesting company to follow this year. Priced just above its all time low as well @ 0.875 pence.)
Fitbug share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:34 V: D:20170118 14:12:53